Literature DB >> 10453878

Hyperlactatemia and pulmonary lactate production in patients with fulminant hepatic failure.

T S Walsh1, S McLellan, S J Mackenzie, A Lee.   

Abstract

STUDY
OBJECTIVES: To determine whether the lungs of patients with fulminant hepatic failure release lactate, and if so, whether this release relates to systemic lactate concentration or acid base status. Another objective was to examine the accuracy of lactate flux calculations in critically ill patients.
DESIGN: Prospective observational study.
SETTING: The ICU of a major teaching hospital. PATIENTS: Twelve patients with fulminant hepatic failure; 30 other critically ill patients in whom a pulmonary artery catheter was in place.
INTERVENTIONS: None. MEASUREMENT AND
RESULTS: The precision of whole-blood lactate measurements was assessed in 30 patients with critical illnesses of variable etiology who had a wide range of arterial lactate concentrations. The reliability of lactate measurements decreased with increasing lactate concentration. In each patient with liver failure, pulmonary lactate flux was calculated on three occasions using the Fick principle. Arterial blood lactate concentration was consistently higher than venous concentrations, indicating lactate release by the lungs (mean difference, 0.15 mmol/L; 95% confidence interval, 0.09 to 0.21; p<0.001). Mean pulmonary lactate production for the 12 patients was 83 mmol/h (range, 22 to 210 mmol/h). No patient had significant acute lung injury. Correlations were found among the arterial lactate concentration and both the arteriovenous (AV) lactate difference (p<0.025) and pulmonary lactate production (p<0.05), but not with acid-base status or cardiac output. The reliability of individual AV lactate difference calculations and pulmonary lactate flux calculations was poor.
CONCLUSION: The lungs release lactate in patients with fulminant hepatic failure at a rate proportional to the degree of systemic hyperlactatemia. However, the measurement errors associated with pulmonary lactate flux calculations using the Fick principle are large, so individual measurements should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10453878     DOI: 10.1378/chest.116.2.471

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  [Stewart's acid-base approach].

Authors:  Georg-Christian Funk
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 2.  Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy.

Authors:  Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  Neurochem Int       Date:  2011-10-01       Impact factor: 3.921

3.  Persistent Hyperlactatemia as the Predictor of Poor Outcome in Critically Ill Children: A Single-Center, Prospective, Observational Cohort Study.

Authors:  Vinayak K Patki; Jennifer V Antin; Shweta H Khare
Journal:  J Pediatr Intensive Care       Date:  2016-11-10

Review 4.  Neuroinflammation in liver disease: sessional talks from ISHEN.

Authors:  Gavin Wright; Mark Swain; Djillali Annane; Faouzi Saliba; Didier Samuel; Vicente Arroyo; Sharon DeMorrow; Anne Witt
Journal:  Metab Brain Dis       Date:  2016-10-11       Impact factor: 3.584

5.  Transpulmonary lactate gradient after hypothermic cardiopulmonary bypass.

Authors:  Karim Bendjelid; Miriam M Treggiari; Jacques-Andre Romand
Journal:  Intensive Care Med       Date:  2004-02-24       Impact factor: 17.440

6.  The concentration of oxygen, lactate and glucose in the central veins, right heart, and pulmonary artery: a study in patients with pulmonary hypertension.

Authors:  Guillermo Gutierrez; Anthony Venbrux; Elizabeth Ignacio; Jonathan Reiner; Lakhmir Chawla; Anish Desai
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 7.  Bench-to-bedside review: lactate and the lung.

Authors:  Fulvio Iscra; Antonino Gullo; Gianni Biolo
Journal:  Crit Care       Date:  2002-06-07       Impact factor: 9.097

Review 8.  Perioperative Management of Lactic Acidosis in End-Stage Liver Disease Patient.

Authors:  Alexander A Vitin; Leonard Azamfirei; Dana Tomescu; John D Lang
Journal:  J Crit Care Med (Targu Mures)       Date:  2017-05-11

Review 9.  Recent advances in hepatic encephalopathy.

Authors:  Victoria Liere; Gurkarminder Sandhu; Sharon DeMorrow
Journal:  F1000Res       Date:  2017-09-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.